HEALTHCAP ADVISOR AB
HEALTHCAP ADVISOR AB is a Seed, Series A, Series B and Series C+ fund in global writing $10M–$50M checks into Healthcare, life-sciences, healthcare-tech and pharma.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, life-sciences, healthcare-tech, pharma
- Check size
- $10M–$50M
- Invests in
- global
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1996
- Assets under management
- $1.3B
Thesis
HealthCap is a European venture capital firm founded in 1996, headquartered in Stockholm, Sweden, with a global investment focus exclusively on the life sciences sector. The firm targets companies developing breakthrough therapies for diseases with significant unmet medical needs, particularly rare diseases, cancers, and genetic disorders, emphasizing precision medicine and innovative therapeutics. HealthCap invests across seed, Series A, Series B, and growth equity stages, with a typical deal size ranging from $10 million to $50 million. They have a strong track record of leading investments.
Common questions
Does HEALTHCAP ADVISOR AB invest at the Seed stage?
Yes. HEALTHCAP ADVISOR AB lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does HEALTHCAP ADVISOR AB write?
HEALTHCAP ADVISOR AB writes $10M–$50M checks.
Where does HEALTHCAP ADVISOR AB invest?
HEALTHCAP ADVISOR AB invests in global.